Federal Trial Delayed for Man Accused of Killing UnitedHealthcare CEO

Judge grants only slight delay, moving trial from September to October

Apr. 1, 2026 at 7:20pm

Got story updates? Submit your updates here. ›

A judge has granted Luigi Mangione a slight delay in his federal trial for the killing of UnitedHealthcare CEO Brian Thompson, moving the trial from September to October. The judge tied the decision to Mangione's upcoming state murder trial, which is set to begin in June and last 4-6 weeks. Mangione's lawyers had argued for a longer delay to avoid back-to-back trials, but the judge rejected that proposal.

Why it matters

This case has garnered significant attention due to the high-profile nature of the victim and the complex legal issues involved. The judge's decision to only grant a slight delay in the federal trial means the two trials will likely proceed on a compressed timeline, raising concerns about Mangione's constitutional rights. The outcome of these trials could have major implications for the criminal justice system's handling of high-profile cases.

The details

U.S. District Judge Margaret Garnett granted Mangione's request to delay the federal trial, but only from September to October. Mangione's lawyers had argued for a delay until January or February 2027 to avoid back-to-back trials, but Garnett rejected that proposal, saying it 'doesn't solve any of these problems.' Jury selection in the federal case will now begin on Oct. 5 instead of Sept. 8, with opening statements and testimony on Oct. 26 instead of Oct. 13. Garnett said the schedule could change again if the state trial is delayed.

  • Mangione's state murder trial is set to begin on June 8 and last 4-6 weeks.
  • Jury selection in the federal case will now begin on Oct. 5 instead of Sept. 8.
  • Opening statements and testimony in the federal case will now begin on Oct. 26 instead of Oct. 13.

The players

Luigi Mangione

A 27-year-old man who has pleaded not guilty to charges related to the killing of UnitedHealthcare CEO Brian Thompson. He faces the possibility of life in prison if convicted in either the federal or state case.

Brian Thompson

The 50-year-old CEO of UnitedHealthcare who was killed on December 4, 2024 as he walked to a Manhattan hotel for UnitedHealth Group's annual investor conference.

Judge Margaret Garnett

The U.S. District Judge presiding over the federal case against Mangione. She previously dismissed a federal murder charge and a gun charge against Mangione, finding the murder charge legally flawed.

Judge Gregory Carro

The state trial judge who previously raised the possibility of moving the state trial to September, but only if federal prosecutors appealed Garnett's decision barring them from seeking the death penalty.

Dominic Gentile

The Assistant U.S. Attorney prosecuting the federal case against Mangione, who argued against a trial delay, stating that witnesses are harder to locate and memories fade with the passage of time.

Got photos? Submit your photos here. ›

What they’re saying

“There really is no way around taking into account the events in the state case. Whether we like it or not, we're at the mercy of the state case.”

— Judge Margaret Garnett, U.S. District Judge

“The public has a right to a speedy trial as well, especially in a case as significant as this.”

— Dominic Gentile, Assistant U.S. Attorney

“It's the same trial twice. One plus one is two. Double jeopardy by any commonsense definition.”

— Luigi Mangione

What’s next

Jury selection in the federal case is now scheduled to begin on October 5, with opening statements and testimony starting on October 26. The schedule could change again if the state trial is delayed.

The takeaway

This case highlights the complex legal issues and scheduling challenges that can arise when a defendant faces both federal and state charges for the same alleged criminal conduct. The judge's decision to only grant a slight delay in the federal trial means Mangione will likely face back-to-back trials, raising concerns about his constitutional rights.